# AI powered Algorithms

Our algorithms provide a quantitative indication of Alzheimier's Disease progression at the **Mild Cognitive Impairment Stage**. The technology assists clinicians by providing an orthogonal biomarker modality to inform early-stage diagnosis alongside traditional AD biomarkers.
